License Agreement

meitle
Jan 28, 2022
1 min read

Scope Law advises the Swiss team of a fast-growing international specialty pharma company in in/out-licensing and IP-transfer agreement negotiations to develop, commercialize and distribute an innovative pharmaceutical products together with partners such as venture capital funds.

Life Sciences

Recent Posts

See All

M&A Transaction

Scope Law advises Jung von Matt IMPACT AG , Zurich, on its strategic participation in the Generation Media AG , Zurich. Jung von Matt...

Financing Round

Scope Law advises ETFbook , Zurich, in its EUR 4 million Series A financing round, led by BlackFin Capital Partners BlackFin Capital...

Financinground

Scope Law advises qCella AG , Zurich, a spin-off of ETH Zurich in its CHF 1.3 million pre-seed financing round. Participating investors...

Comments